The use of non-economic criteria in pricing and reimbursement decisions in Central and Eastern Europe: issues, trends and recommendations

References

• Draborg E, Gyrd-Hansen D, Bo Poulsen P, et al. International comparison of the definition and the practical application of health technology assessment. Int J Technol Assess Health Care. 2005;21(1):89–95.
   PubMed Web of Science ®Google Scholar
• Barnieh L. A synthesis of drug reimbursement decision-making processes in organisation for economic co-operation and development countries. Value Health. 2014;17:98–108.
   PubMed Web of Science ®Google Scholar
• EUnetHTA and the HTA network. [ cited 2015 Dec 17]. Available from: http://www.eunethta.eu/
   Google Scholar
• European Commission. Process on corporate social responsibility in the field of pharmaceuticals platform on access to medicines in Europe Working Group on mechanism of coordinated access to orphan medicinal products (MoCA-OMP). [ cited 2016 Apr 17]. Available from: http://ec.europa.eu/DocsRoom/documents/7631?locale=pl
   Google Scholar
• Culyer T. Where are the limits of cost-effectiveness analysis and health technology assessment? J Med Assoc Thai. 2014;97(Suppl. 5):S1–S2.
   Google Scholar
• The Department of Health. Life Saving Drugs Programme (LSDP). [ cited 2015 Dec 17]. Available from: http://www.health.gov.au/LSDP
   Google Scholar
• NICE. Interim process and methods of the highly specialised technologies programme. [ cited 2015 Dec 17]. Available from: https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-highly-specialised-technologies-guidance/Highly-Specialised-Technologies-Interim-methods-and-process-statements.pdf
   Google Scholar
• Diaby V, Goeree R. How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: a step-by-step guide. Expert Rev Pharmacoecon Outcomes Res. 2014;14(1):81–99.
   PubMed Web of Science ®Google Scholar
• Multiple criteria decision analysis for health care decision making—an introduction: report 1 of the ISPOR MCDA emerging good practices task force. [ cited 2016 Jan 15]. Available from: http://www.ispor.org/Multi-Criteria-Decision-Analysis-guideline.pdf
   Google Scholar
• Health inequalities. [cited 2015 Dec 18]. Available from: http://preview.euphix.org/object_document/o5556n29797.html
   Google Scholar
• Mackenbach J, Meerding W, Kunst A Economic implications of socio-economic inequalities in health in the European Union. Directorate-General for Health and Consumers, European Commission; 2007 [cited 2015 Dec 17]. Available from: http://ec.europa.eu/health/ph_determinants/socio_economics/documents/socioe-co_inequalities_en.pdf
   Google Scholar
• OECD health data. [cited 2015 Jul 20]. Available from: www.oecd.org
   Google Scholar
• Angelis R, Sant M, Coleman M, et al. Cancer survival in Europe 1999—2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014 Jan;15(1):23–34.
   PubMed Web of Science ®Google Scholar
• Sanger-Katz M. Income inequality: it’s also bad for your health. 2015 Mar 30 [cited 2015 Jul 20]. Available from: http://www.nytimes.com/2015/03/31/upshot/income-inequality-its-also-bad-for-your-health.html?ref=business&abt=0002&abg=1&_r=0
   Google Scholar
• EFPIA W.A.I.T. indicator report 2011. [ cited 2015 Jul 20]. Available from: http://www.efpia.eu/uploads/Patients_WAIT_Report_2011_FINAL_070811_1.doc
   Google Scholar
• EY Poland. Access to innovative cancer drugs in Poland in comparison with selected European Union countries and Switzerland. 2015 Apr [cited 2015 Jul 20]. Available at: http://www.alivia.org.pl/raport2015/05_05_2015_Raport_wersja_EN.pdf
   Google Scholar
• Mackenbach J, Meerding W, Kunst A Economic implications of socio-economic inequalities in health in the European Union. Directorate-General for Health and Consumers, European Commission; 2007 [cited 2015 Jul 20]. Available from: http://ec.europa.eu/health/ph_determinants/socio_economics/documents/socioe-co_inequalities_en.pdf
   Google Scholar
• OECD. Health care systems: getting more value for money. OECD Economics Department Policy Notes, No. 2; [ cited 2015 Jul 20].. Available from: http://www.oecd.org/els/health-systems/health-data.htm
   Google Scholar
• OECD European Union. Health at a glance: Europe 2014. Paris: OECD; 2014 [cited 2015 Jul 20]. doi:10.1787/health_glance_eur-2014-en.
   Google Scholar
• United Nations, Department of Economic and Social Affairs, Population Division. World population ageing 2013. ST/ESA/SER.A/348. 2013 [cited 2015 Jul 20]. Available from: http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf
   Google Scholar
• Murthi M. In Europe, life gets shorter for some. The World Bank; 2015 Apr [cited 2015 Dec 18]. Available from: http://www.worldbank.org/en/news/opinion/2015/04/22/in-europe-life-gets-shorter-for-some
   Google Scholar
• OECD. What future for health spending? OECD Economics Department Policy Notes, No. 19; 2013 Jun [cited 2015 Jul 20]. Available from: http://www.oecd.org/economy/health-spending.pdf
   Google Scholar
• OECD. Health data 2015. [ cited 2016 Apr 17]. Available from: https://data.oecd.org/healthres/pharmaceutical-spending.htm
   Google Scholar
• The pharmaceutical law and the act on the reimbursement of medicines, foodstuffs intended for particular nutritional uses and medical devices in Poland (Dz. U. z 2011 r. Nr 122, poz. 696) [Internet]. [cited 2016 Jul 22]. Available from: http://isap.sejm.gov.pl/DetailsServlet?id=WDU20111220696.
   Google Scholar
• Kwong D, Ferrario A, Adamski J, et al. Managing the introduction of new and high-cost drugs in challenging times: the experience of Hungary and Poland. Eurohealth. 2014;20(2):25–28.
   Google Scholar
• Koechlin F., Konijn P, Lorenzoni L, et al. Comparing hospital and health prices and volumes internationally: results of a Eurostat/OECD project. OECD Health Working Papers, No. 75. Paris: OECD; 2014. doi:10.1787/5jxznwrj32mp-en.
   Google Scholar
• Skoupá J, Annemans L, Hájek P. Health economic data requirements and availability in the European Union: results of a survey among 10 European countries. Value Health Reg Issues. 2014;4(C):53–57.
   Google Scholar
• Bjornberg A. Euro health consumer index 2014. Health Consumer Powerhouse; 2015 [cited 2015 Jul 20]. Available from: http://www.healthpowerhouse.com/files/EHCI_2014/EHCI_2014_report.pdf
   Google Scholar
• Culyer T, Wagstaff A Need, equity and equality in health and health care. University of York. Centre for Health Economics, Discussion Paper 95; 1992 Feb [cited 2016 Apr 20]. Available from: http://www.york.ac.uk/che/pdf/DP95.pdf
   Google Scholar
• Czapiński J. Stan społeczeństwa obywatelskiego. Postawy i relacje społeczne. Diagnoza Społeczna 2013 Warunki i Jakość Życia Polaków - Raport [Special issue]. Contemp Econ. 2013;7:268–274. doi:10.5709/ce.1897-9254.108.
   Google Scholar
• Kolasa K, Annemans L, Lees M. Attitudes toward supplementary criteria in the reimbursement process in Poland. Int J Technol Assess Health Care. 2013 Oct;29(4):443–449.
   PubMed Web of Science ®Google Scholar
• New £50 million cancer fund already intellectually bankrupt. Lancet. 2010 Aug 7;376(9739):389.
   PubMed Web of Science ®Google Scholar
• Zah V Structuring evidence using Multi- Criteria Decision Analysis (MCDA). [cited 2015 Dec 18]. www.ispor.org/Event/GetReleasedPresentation/394
   Google Scholar
• The upper house of the Polish parliament: responses to the members of the upper house of the Polish parliament, 64th meeting, Warsaw. 2015 [cited 2015 Mar 19]. http://www.senat.gov.pl/gfx/senat/userfiles/_public/k8/dokumenty/stenogram/odpow64sw.pdf
   Google Scholar